Discontinued — last reported Q1 '20
Equity Securities Without Readily Determinable Fair Value
Non-Current AssetsUnitedHealth Group Equity Securities Without Readily Determinable Fair Value increased by 3.7% to $5.60B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $4.90B to $5.60B. Over 4 years (FY 2020 to FY 2024), Equity Securities Without Readily Determinable Fair Value shows an upward trend with a 20.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2020
How to read this metric
An increase suggests a strategic shift toward private market investments or long-term partnerships with non-public entities.
Detailed definition
This represents the carrying amount of equity investments for which a readily determinable market price is not available...
Peer comparison
Common for large corporations with active corporate venture capital or strategic partnership programs.
Metric ID:
equity_securities_without_fair_valueHistorical Data
16 periods
| Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.90B | $3.50B | $3.40B | $3.40B | $3.70B | $3.90B | $4.20B | $4.20B | $4.90B | $4.10B | $4.20B | $4.90B | $4.90B | $5.10B | $5.40B | $5.60B |
| QoQ Change | — | +20.7% | -2.9% | +0.0% | +8.8% | +5.4% | +7.7% | +0.0% | +16.7% | -16.3% | +2.4% | +16.7% | +0.0% | +4.1% | +5.9% | +3.7% |
| YoY Change | — | — | — | +17.2% | +5.7% | — | +23.5% | +23.5% | +32.4% | +5.1% | +0.0% | +16.7% | +0.0% | +24.4% | +28.6% | +14.3% |
Range$2.90B – $5.60B
CAGR+19.2%
Avg YoY Growth+16.0%
Median YoY Growth+17.0%
Current Streak6 quarters growth
Equity Securities Without Readily Determinable Fair Value at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's equity securities without readily determinable fair value?
- UnitedHealth Group (UNH) reported equity securities without readily determinable fair value of $5.60B in Q3 2025.
- How has UnitedHealth Group's equity securities without readily determinable fair value changed year-over-year?
- UnitedHealth Group's equity securities without readily determinable fair value increased by 14.3% year-over-year, from $4.90B to $5.60B.
- What is the long-term trend for UnitedHealth Group's equity securities without readily determinable fair value?
- Over 4 years (2020 to 2024), UnitedHealth Group's equity securities without readily determinable fair value has grown at a 20.8% compound annual growth rate (CAGR), from $2.30B to $4.90B.
- What does equity securities without readily determinable fair value mean?
- The value of private or non-public company investments held by the firm.